McDaniel College begins a $3.6 million renovation to install a learning commons in the Hoover Library in Westminster ...

From the euphoric vibes at ULTRA to the snow-covered stages of Rise Music Festival, the coastal grooves at Defected Croatia, ...

The drugs were first approved to treat type 2 diabetes – and that's what the FDA said daily injections of liraglutide could ...

The U.S. Food and Drug Administration (FDA) has approved the first prescription medication specifically for treating ...

Lilly and Novo still dominate the market for weight-loss and diabetes drugs, but the race is heating up in more ways than one ...

The nod, just months after topline results from SURMOUNT-OSA came out, makes it the first drug approved for this indication.

Stocks shook off a choppy start to finish higher Monday, as Wall Street kicked off a holiday-shortened week. The S&P 500 ...

Tirzepatide, the active ingredient in both Mounjaro for type 2 diabetes and Zepbound for weight loss, was in short supply for ...

If you have sleep apnea and obesity, tirzepatide Zepbound may offer relief and support weight loss. Ask your doctor if it’s a ...

Eli Lilly and Company (NYSE: LLY) shares are trading higher Monday. The upward momentum in the stock comes after the FDA approved the company's Zepbound, a weight loss drug designed to treat ...

Up to half of obstructive sleep apnea patients taking Zepbound had no symptoms after one year of treatment, averaging 25 ...

The U.S. Food and Drug Administration has revoked the emergency use authorization for four COVID-19 antibody-based drugs, ...